Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-Sectional Study To Investigate The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

NCT01526304 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01526304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01526304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-Sectional Study To Investigate The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
January 31, 2014
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney stones